These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28238427)

  • 1. Development of a non-radiolabeled glucosyltransferase activity assay for C. difficile toxin A and B using ultra performance liquid chromatography.
    Loughney JW; Lancaster C; Price CE; Hoang VM; Ha S; Rustandi RR
    J Chromatogr A; 2017 May; 1498():169-175. PubMed ID: 28238427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
    D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
    BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
    Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB
    J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques.
    Zeiser J; Gerhard R; Just I; Pich A
    J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the glucosyltransferase domain of TcdA in complex with RhoA provides insights into substrate recognition.
    Chen B; Liu Z; Perry K; Jin R
    Sci Rep; 2022 May; 12(1):9028. PubMed ID: 35637242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of Clostridium difficile toxin A glucosyltransferase domain bound to Mn2+ and UDP provides insights into glucosyltransferase activity and product release.
    D'Urzo N; Malito E; Biancucci M; Bottomley MJ; Maione D; Scarselli M; Martinelli M
    FEBS J; 2012 Sep; 279(17):3085-97. PubMed ID: 22747490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clostridium difficile toxins: more than mere inhibitors of Rho proteins.
    Genth H; Dreger SC; Huelsenbeck J; Just I
    Int J Biochem Cell Biol; 2008; 40(4):592-7. PubMed ID: 18289919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A.
    Kreimeyer I; Euler F; Marckscheffel A; Tatge H; Pich A; Olling A; Schwarz J; Just I; Gerhard R
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):253-62. PubMed ID: 21046073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile Toxin Biology.
    Aktories K; Schwan C; Jank T
    Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene.
    Olling A; Seehase S; Minton NP; Tatge H; Schröter S; Kohlscheen S; Pich A; Just I; Gerhard R
    Microb Pathog; 2012 Jan; 52(1):92-100. PubMed ID: 22107906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lectin Activity of the TcdA and TcdB Toxins of Clostridium difficile.
    Hartley-Tassell LE; Awad MM; Seib KL; Scarselli M; Savino S; Tiralongo J; Lyras D; Day CJ; Jennings MP
    Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30530621
    [No Abstract]   [Full Text] [Related]  

  • 12. Harnessing the glucosyltransferase activities of Clostridium difficile for functional studies of toxins A and B.
    Darkoh C; Kaplan HB; Dupont HL
    J Clin Microbiol; 2011 Aug; 49(8):2933-41. PubMed ID: 21653766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional properties of the carboxy-terminal host cell-binding domains of the two toxins, TcdA and TcdB, expressed by Clostridium difficile.
    Dingle T; Wee S; Mulvey GL; Greco A; Kitova EN; Sun J; Lin S; Klassen JS; Palcic MM; Ng KK; Armstrong GD
    Glycobiology; 2008 Sep; 18(9):698-706. PubMed ID: 18509107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a neutralizing antibody helps identify structural features critical for binding of
    Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
    J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
    [No Abstract]   [Full Text] [Related]  

  • 15. Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.
    Zhang Y; Hamza T; Gao S; Feng H
    Biochem Biophys Res Commun; 2015 Apr; 459(2):259-263. PubMed ID: 25725153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TcdB of
    Stieglitz F; Gerhard R; Hönig R; Giehl K; Pich A
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning, overexpression in Escherichia coli, and purification of 6x his-tagged C-terminal domain of Clostridium difficile toxins A and B.
    Letourneur O; Ottone S; Delauzun V; Bastide MC; Foussadier A
    Protein Expr Purif; 2003 Oct; 31(2):276-85. PubMed ID: 14550648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile toxin glucosyltransferase domains in complex with a non-hydrolyzable UDP-glucose analogue.
    Alvin JW; Lacy DB
    J Struct Biol; 2017 Jun; 198(3):203-209. PubMed ID: 28433497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a dose assay for a Clostridium difficile vaccine using a tandem ion exchange high performance liquid chromatography method.
    Wang F; Ha S; Rustandi RR
    J Chromatogr A; 2017 May; 1498():163-168. PubMed ID: 28366569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Clostridium difficile Infection with a Small-Molecule Inhibitor of Toxin UDP-Glucose Hydrolysis Activity.
    Stroke IL; Letourneau JJ; Miller TE; Xu Y; Pechik I; Savoly DR; Ma L; Sturzenbecker LJ; Sabalski J; Stein PD; Webb ML; Hilbert DW
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.